Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines

Table 2

Percentage of live, early apoptotic, late apoptotic, and dead cells by the Muse Annexin V and Dead Cell assay in Huh7 (a) and HepG2 (b) cell lines.

(a)

	CTRL	TACR	DOX	Cotreat
Live	83.34%	31.57%	9.39%	0.81%
Early apoptosis	11.42%	54.18%	1.46%	0.52%
Late apoptosis	4.95%	14.25%	88.96%	98.66%
Dead	0.28%	0%	0.20%	0%

(b)

	CTRL	TACR	DOX	Cotreat
Live	70.29%	42.18%	11.51%	3.72%
Early apoptosis	16.70%	28.27%	57.07%	11.62%
Late apoptosis	12.40%	26.96%	30.43%	84.45%
Dead	0.65%	2.61%	1.00%	0.21%